146 related articles for article (PubMed ID: 37538202)
1. Immunohistochemical Expression of E-Cadherin and β-Catenin in Oral Squamous Cell Carcinoma.
Akinyamoju AO; Lawal AO; Adisa AO; Adeyemi BF; Kolude B
J West Afr Coll Surg; 2023; 13(3):43-47. PubMed ID: 37538202
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of the Epithelial to Mesenchymal Transition Proteins E-cadherin and ß-catenin in Grades of Oral Squamous Cell Carcinoma.
Kumar V; Panda A; Dash KC; Bhuyan L; Mahapatra N; Mishra P
J Pharm Bioallied Sci; 2021 Jun; 13(Suppl 1):S555-S560. PubMed ID: 34447152
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
4. Immunodetection of Epithelial-Mesenchymal Transition and Tumor Proliferation Markers in GLi-1-positive Oral Squamous Cell Carcinoma.
Dantas RCM; Guimarães VSN; de Souza RO; Valverde LF; Vidal MTA; Nogueira RLR; da Rocha LOS; Araújo GT; Dos Santos JN; Rocha CAG
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):335-344. PubMed ID: 32769440
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Evaluation of E- Cadherin in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Jain A; Gupta A
J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1838-S1842. PubMed ID: 38882719
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
8. E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases.
Fadare O; Reddy H; Wang J; Hileeto D; Schwartz PE; Zheng W
World J Surg Oncol; 2005 Jun; 3():38. PubMed ID: 15969753
[TBL] [Abstract][Full Text] [Related]
9. Correlation of E-cadherin Immunohistochemical Expression with Histopathological Grading of Oral Squamous Cell Carcinoma.
Kushwaha SS; Joshi S; Arora KS; Kushwaha NS; Sharma S; Saini DS
Contemp Clin Dent; 2019; 10(2):232-238. PubMed ID: 32308283
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
Kalaimani G; Rao UDK; Joshua E; Ranganathan K
Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of E-Cadherin and Cyclin D1 in different grades of oral squamous cell carcinoma.
Dar MS; Abbas R; Shah Z; Latoo SH; Gowhar O
J Oral Maxillofac Pathol; 2023; 27(3):476-480. PubMed ID: 38033971
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.
Kaur J; Sawhney M; DattaGupta S; Shukla NK; Srivastava A; Walfish PG; Ralhan R
PLoS One; 2013; 8(6):e67361. PubMed ID: 23840677
[TBL] [Abstract][Full Text] [Related]
13. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
[TBL] [Abstract][Full Text] [Related]
14. Concomitant loss of p120-catenin and β-catenin membrane expression and oral carcinoma progression with E-cadherin reduction.
Sasaya K; Sudo H; Maeda G; Kawashiri S; Imai K
PLoS One; 2013; 8(8):e69777. PubMed ID: 23936352
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Epithelial Mesenchymal Transition Proteins in Squamous Cell Carcinoma of the Oral Cavity.
Kadeh H; Saravani S; Miri Moghaddam E
Iran J Pathol; 2021; 16(4):354-361. PubMed ID: 34567183
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
[TBL] [Abstract][Full Text] [Related]
18. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?
Hanemann JA; Oliveira DT; Nonogaki S; Nishimoto IN; de Carli ML; Landman G; Kowalski LP
BMC Cancer; 2014 Jun; 14():395. PubMed ID: 24893577
[TBL] [Abstract][Full Text] [Related]
20. A Correlative Study of N-Cadherin Expression with Different Grades of Oral Squamous Cell Carcinoma Projecting as a Marker of Epithelial to Mesenchymal Transition in Tumor Progression.
Rai K H; Ahmed J
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2327-2332. PubMed ID: 31450902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
